NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supplying essential chemical compounds that fuel scientific research. Among its portfolio, (3-Carboxypropyl)triphenylphosphonium Bromide, identified by CAS 17857-14-6, is a compound of significant interest due to its diverse research applications. This versatile chemical serves as both a critical pharmaceutical intermediate and a specialized mitochondrial targeting reagent, areas of intense focus in modern biological and medical sciences.

The precise synthesis of 3-carboxypropyl triphenylphosphonium bromide is a cornerstone of its reliable use in research. NINGBO INNO PHARMCHEM CO.,LTD. ensures that this process yields a product of exceptional purity and consistency, vital for accurate experimental outcomes. Researchers can confidently buy chemical reagents from us, knowing they are acquiring materials that meet rigorous scientific standards. This commitment is especially important for a key CAS 17857-14-6 pharmaceutical intermediate used in the development of new drugs.

As a mitochondrial targeting reagent, (3-Carboxypropyl)triphenylphosphonium Bromide allows scientists to investigate cellular processes within mitochondria, the energy centers of cells. This capability is crucial for understanding various diseases, including metabolic disorders and neurodegenerative conditions, and for developing therapies that specifically act on these organelles. The ability to deliver agents directly to mitochondria is a significant advancement in targeted therapy.

Moreover, this compound is an essential precursor in the synthesis of sphingosine 1-phosphate-1 receptor antagonists, which are being explored for their therapeutic potential in various diseases. The availability of this key building block is instrumental in accelerating drug discovery pipelines. NINGBO INNO PHARMCHEM CO.,LTD. provides this vital pharmaceutical intermediate, empowering researchers to move their projects forward efficiently. Our role as a reliable supplier ensures that the scientific community has consistent access to the tools they need for groundbreaking work in medicinal chemistry and beyond.